vs
Creative Media & Community Trust Corp（CMCT）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
RECURSION PHARMACEUTICALS, INC.的季度营收约是Creative Media & Community Trust Corp的1.2倍（$35.5M vs $28.5M），Creative Media & Community Trust Corp净利率更高（-125.8% vs -304.2%，领先178.5%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 3.6%），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs -8.5%）
Creative Media & Community Trust Corp是一家总部位于美国的房地产投资信托企业，核心运营两大板块：持有、管理及开发专业影视制作工作室等创意媒体设施，以及经济适用房、社区医疗中心、邻里商业空间等民生类物业，服务传媒客户及各地社区居民。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
CMCT vs RXRX — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $28.5M | $35.5M |
| 净利润 | $-11.4M | $-108.1M |
| 毛利率 | — | 59.8% |
| 营业利润率 | -125.6% | -304.8% |
| 净利率 | -125.8% | -304.2% |
| 营收同比 | 3.6% | 681.7% |
| 净利润同比 | -11.4% | 39.6% |
| 每股收益（稀释后） | $-3.89 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $28.5M | $35.5M | ||
| Q3 25 | $26.2M | $5.2M | ||
| Q2 25 | $29.7M | $19.2M | ||
| Q1 25 | $32.3M | $14.7M | ||
| Q4 24 | $27.5M | $4.5M | ||
| Q3 24 | $28.6M | $26.1M | ||
| Q2 24 | $34.4M | $14.4M | ||
| Q1 24 | $34.0M | $13.8M |
| Q4 25 | $-11.4M | $-108.1M | ||
| Q3 25 | $-12.5M | $-162.3M | ||
| Q2 25 | $-9.0M | $-171.9M | ||
| Q1 25 | $-6.1M | $-202.5M | ||
| Q4 24 | $-10.3M | $-178.9M | ||
| Q3 24 | $-10.4M | $-95.8M | ||
| Q2 24 | $-796.0K | $-97.5M | ||
| Q1 24 | $-3.7M | $-91.4M |
| Q4 25 | — | 59.8% | ||
| Q3 25 | — | -183.8% | ||
| Q2 25 | — | -4.9% | ||
| Q1 25 | — | -48.0% | ||
| Q4 24 | — | -181.4% | ||
| Q3 24 | — | 53.7% | ||
| Q2 24 | — | 36.2% | ||
| Q1 24 | — | 19.1% |
| Q4 25 | -125.6% | -304.8% | ||
| Q3 25 | -47.7% | -3327.6% | ||
| Q2 25 | -30.3% | -916.8% | ||
| Q1 25 | -19.0% | -1297.9% | ||
| Q4 24 | -128.8% | -4042.4% | ||
| Q3 24 | -36.9% | -377.1% | ||
| Q2 24 | -1.6% | -697.4% | ||
| Q1 24 | -10.7% | -698.4% |
| Q4 25 | -125.8% | -304.2% | ||
| Q3 25 | -47.5% | -3135.3% | ||
| Q2 25 | -30.3% | -894.2% | ||
| Q1 25 | -18.9% | -1373.3% | ||
| Q4 24 | -129.8% | -3935.5% | ||
| Q3 24 | -36.3% | -367.5% | ||
| Q2 24 | -2.3% | -676.6% | ||
| Q1 24 | -11.0% | -662.4% |
| Q4 25 | $-3.89 | $-0.17 | ||
| Q3 25 | $-23.52 | $-0.36 | ||
| Q2 25 | $-18.94 | $-0.41 | ||
| Q1 25 | $-20.73 | $-0.50 | ||
| Q4 24 | $97.71 | $-0.56 | ||
| Q3 24 | $-305.04 | $-0.34 | ||
| Q2 24 | $-98.64 | $-0.40 | ||
| Q1 24 | $-125.46 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $15.4M | $743.3M |
| 总债务越低越好 | $509.8M | $9.6M |
| 股东权益账面价值 | $265.4M | $1.1B |
| 总资产 | $859.2M | $1.5B |
| 负债/权益比越低杠杆越低 | 1.92× | 0.01× |
8季度趋势，按日历期对齐
| Q4 25 | $15.4M | $743.3M | ||
| Q3 25 | $17.3M | $659.8M | ||
| Q2 25 | $27.8M | $525.1M | ||
| Q1 25 | $19.8M | $500.5M | ||
| Q4 24 | $20.3M | $594.4M | ||
| Q3 24 | $18.5M | $427.6M | ||
| Q2 24 | $29.3M | $474.3M | ||
| Q1 24 | $21.3M | $296.3M |
| Q4 25 | $509.8M | $9.6M | ||
| Q3 25 | $527.8M | $11.9M | ||
| Q2 25 | $535.6M | $14.2M | ||
| Q1 25 | $512.7M | $16.4M | ||
| Q4 24 | $505.7M | $19.0M | ||
| Q3 24 | $478.3M | $20.5M | ||
| Q2 24 | $485.1M | $22.9M | ||
| Q1 24 | $472.8M | — |
| Q4 25 | $265.4M | $1.1B | ||
| Q3 25 | $281.9M | $1.0B | ||
| Q2 25 | $287.1M | $919.1M | ||
| Q1 25 | $293.0M | $933.9M | ||
| Q4 24 | $304.5M | $1.0B | ||
| Q3 24 | $321.0M | $524.6M | ||
| Q2 24 | $351.1M | $584.4M | ||
| Q1 24 | $369.9M | $401.2M |
| Q4 25 | $859.2M | $1.5B | ||
| Q3 25 | $871.8M | $1.4B | ||
| Q2 25 | $885.0M | $1.3B | ||
| Q1 25 | $882.3M | $1.3B | ||
| Q4 24 | $889.6M | $1.4B | ||
| Q3 24 | $868.0M | $726.5M | ||
| Q2 24 | $891.2M | $775.9M | ||
| Q1 24 | $887.5M | $557.8M |
| Q4 25 | 1.92× | 0.01× | ||
| Q3 25 | 1.87× | 0.01× | ||
| Q2 25 | 1.87× | 0.02× | ||
| Q1 25 | 1.75× | 0.02× | ||
| Q4 24 | 1.66× | 0.02× | ||
| Q3 24 | 1.49× | 0.04× | ||
| Q2 24 | 1.38× | 0.04× | ||
| Q1 24 | 1.28× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $5.8M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | — | $-47.3M |
| 自由现金流率自由现金流/营收 | — | -133.1% |
| 资本支出强度资本支出/营收 | — | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-378.3M |
8季度趋势，按日历期对齐
| Q4 25 | $5.8M | $-46.1M | ||
| Q3 25 | $3.7M | $-117.4M | ||
| Q2 25 | $-2.5M | $-76.4M | ||
| Q1 25 | $1.2M | $-132.0M | ||
| Q4 24 | $17.0M | $-115.4M | ||
| Q3 24 | $10.3M | $-59.2M | ||
| Q2 24 | $3.9M | $-82.2M | ||
| Q1 24 | $1.6M | $-102.3M |
| Q4 25 | — | $-47.3M | ||
| Q3 25 | — | $-117.6M | ||
| Q2 25 | — | $-79.6M | ||
| Q1 25 | — | $-133.8M | ||
| Q4 24 | — | $-116.7M | ||
| Q3 24 | — | $-63.8M | ||
| Q2 24 | — | $-83.4M | ||
| Q1 24 | — | $-109.0M |
| Q4 25 | — | -133.1% | ||
| Q3 25 | — | -2272.5% | ||
| Q2 25 | — | -413.9% | ||
| Q1 25 | — | -907.4% | ||
| Q4 24 | — | -2567.7% | ||
| Q3 24 | — | -244.6% | ||
| Q2 24 | — | -578.5% | ||
| Q1 24 | — | -789.9% |
| Q4 25 | — | 3.5% | ||
| Q3 25 | — | 4.7% | ||
| Q2 25 | — | 16.4% | ||
| Q1 25 | — | 12.4% | ||
| Q4 24 | — | 28.6% | ||
| Q3 24 | — | 17.5% | ||
| Q2 24 | — | 8.2% | ||
| Q1 24 | — | 48.2% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
